Long-term results after radical prostatectomy for prostate cancer
Follows men 10 years after radical prostatectomy for prostate cancer.
Plain-language title generated from the registry record
Registry title: Predictive Factors for 10-year Biochemical Recurrence and Urinary Continence Following Robot-assisted Radical Prostatectomy for Prostate Cancer
Key facts
- Where
- Banská Bystrica, SlovakiaSee the site
Where in Slovakia
- F.D. Roosvelt university hospitalBanská Bystrica, SlovakiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica
- Trial code
- NCT07439913
- Record updated
- 27 April 2026
- Original description
The aim of the present project is to evaluate long-term oncological and functional treatment outcomes, as well as patient satisfaction, ten years after radical prostatectomy in patients initially enrolled in CPRRP study. This research builds on a previous five-year follow-up evaluation (approved by the ethics committee) and focuses on the durability of therapeutic effects, quality of life, and long-term complications. Data will be collected via telephone interviews assessing key parameters (PSA levels, information on subsequent radiotherapy and androgen-deprivation therapy, the ICIQ-SF and IIEF-5 questionnaires, and patient-reported quality-of-life and satisfaction measures), followed by statistical analysis.Read full original descriptionShow less
Ten-Year Oncologic and Functional Results of Prostate Cancer Treatment by Radical Prostatectomy and the Rate of Patient Satisfaction
The aim of the present project is to evaluate long-term oncological and functional treatment outcomes, as well as patient satisfaction, ten years after radical prostatectomy in patients initially enrolled in CPRRP study. This research builds on a previous five-year follow-up evaluation (approved by the ethics committee) and focuses on the durability of therapeutic effects, quality of life, and long-term complications. Data will be collected via telephone interviews assessing key parameters (PSA levels, information on subsequent radiotherapy and androgen-deprivation therapy, the ICIQ-SF and IIEF-5 questionnaires, and patient-reported quality-of-life and satisfaction measures), followed by statistical analysis.
Inclusion: Robot assisted radical prostatectomy performed in CPRRP study.
Exclusion: -.